How is registration completed?
Registration is completed using an online form
Principal Investigators are required to provide the following to the IBC:
- Centers and Labs
- Center for Clinical and Applied Genomics
- Center for Cardiac Research
- Center for Clinical Diagnostics
- Center for Pediatric Auditory and Speech Sciences (CPASS)
- Center for Endocrinology, Diabetes and Metabolic Disorders
- 2009 Progress Report
- Hypoglycemia in Children with T1DM: Mechanisms and Prevention
- Placebo-controlled Trial to Assess Anastrozole (ARIMIDEX)
- Therapeutic Intervention on Cardiovascular Risk Markers
- Nutrients & Hormones: Effects in Boys with Disordered Growth
- Patients with T1DM: Relation to Glycemic Variability
- Glutathione Homeostasis in Adolescent Type I Diabetes
- Study of the Effect of Continuous Subcutaneous Insulin Infusion
- C-Type Natriuretic Peptide levels in healthy children
- Amino-Terminal Propeptide of C-Type Natriuretic Peptide
- Multi-Center Studies
- Center for Pediatric Psychology Research
- Center for Pediatric Lung Research
- Center for Childhood Cancer Research
- Center for Pediatric Research
- Center for Pediatric Clinical Research and Development
- Center for Orthopedics Research and Development (CORD)
- Center for Pharmacogenomics and Translational Research
- Center for Integrative Pediatric Obesity Care
- Core Laboratories
- Clinical Trials
- Algorithms for Processing of Self-Monitoring Blood Glucose Data
- Amblyopia Treatment Studies
- Behavior Therapy for Families of Diabetic Adolescents
- Continuous Glucose Sensors in Youth: Biobehavioral Study
- Family Management of Childhood Diabetes (Type 1)
- Family Management of Childhood Diabetes: Clinical Site
- Home-Based Versus Office-Based Family Therapy for Diabetes
- Effect of a high-frequency, low-magnitude vibration on bone
- Cystic Fibrosis Foundation Patient Registry
- Vesicoureteral Reflux Study
- Clinical Lab Services
- Clinical Immunology
- Gastroenterology Clinical Laboratory
- Molecular Diagnostics
- Allan-Herndon-Dudley Syndrome
- Autosomal Dominant Leukodystrophy
- Barth Syndrome
- Cardio-Facio-Cutaneous Syndrome
- Costello Syndrome
- Duchenne Muscular Dystrophy
- Emery-Dreifuss Muscular Dystrophy
- Escobar Syndrome
- Familial Isolated Hypoparathyroidism
- Fatal Infantile Cardioencephalomyopathy
- Feingold Syndrome
- GJB2 & GJB6 Related Disorders
- Hypomyelination and Congenital Cataract
- Microcephalic Osteodysplastic Primordial Dwarfism, Type II
- NKX2-1 Related Disorders
- Noonan/LEOPARD Syndrome
- Pelizaeus-Merzbacher-Like Disease
- Pendred Syndrome and DFNB4
- Pelizaeus Merzbacher Disease
- Rett Syndrome
- Spinal Muscular Atrophy
- TARP Syndrome
- Timothy Syndrome
- TRPV4-Related Neuropathies
- TRPV4-Related Skeletal Dysplasias
- Transplant Molecular Diagnostics
- Muscle Enzyme Histochemistry Lab
- Faculty and Staff
- Committees
- Human Subject Protections: NOHSP
- Education
- Publications
- Technology Transfer
- IDeA Networks of Biomedical Research Excellence
- Delaware Health Sciences Alliance
- Contact Us
Registration of Research with the IBC at Nemours
- A biosafety level assessment of the proposed work
- Sufficient information to confirm that the correct biosafety level has been selected and sufficient detail to evaluate adherence with NIH, CDC, and OSHA regulatory guidelines.
Notification from the IBC regarding the submission will be returned by email.
Why is IBC registration needed?
To assure that Principal Investigators have sufficient biosafety training to carry out the proposed research.
To confirm that work will be carried out at the appropriate biosafety level (BSL) and with appropriate safeguards in place.
Who needs to register?
Principal investigators are responsible for registering their research activities.